nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—AR—scrotum—urinary bladder cancer	0.246	0.43	CbGeAlD
Nandrolone phenpropionate—AR—penis—urinary bladder cancer	0.111	0.194	CbGeAlD
Nandrolone phenpropionate—CYP19A1—prostate gland—urinary bladder cancer	0.0299	0.0524	CbGeAlD
Nandrolone phenpropionate—AR—prostate gland—urinary bladder cancer	0.0265	0.0464	CbGeAlD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.0226	0.0573	CbGpPWpGaD
Nandrolone phenpropionate—AR—seminal vesicle—urinary bladder cancer	0.0224	0.0392	CbGeAlD
Nandrolone phenpropionate—AR—epithelium—urinary bladder cancer	0.0195	0.0341	CbGeAlD
Nandrolone phenpropionate—AR—smooth muscle tissue—urinary bladder cancer	0.0187	0.0328	CbGeAlD
Nandrolone phenpropionate—AR—renal system—urinary bladder cancer	0.018	0.0316	CbGeAlD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDX1—urinary bladder cancer	0.018	0.0455	CbGpPWpGaD
Nandrolone phenpropionate—AR—urethra—urinary bladder cancer	0.0177	0.031	CbGeAlD
Nandrolone phenpropionate—CYP19A1—female reproductive system—urinary bladder cancer	0.0163	0.0286	CbGeAlD
Nandrolone phenpropionate—AR—female reproductive system—urinary bladder cancer	0.0144	0.0253	CbGeAlD
Nandrolone phenpropionate—AR—vagina—urinary bladder cancer	0.0131	0.0229	CbGeAlD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.0108	0.0274	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.0107	0.0271	CbGpPWpGaD
Nandrolone phenpropionate—Ethynodiol—ESR1—urinary bladder cancer	0.01	0.298	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PHB—urinary bladder cancer	0.00966	0.0244	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—lymph node—urinary bladder cancer	0.00955	0.0167	CbGeAlD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.0088	0.0222	CbGpPWpGaD
Nandrolone phenpropionate—Norgestimate—ESR1—urinary bladder cancer	0.00852	0.254	CrCbGaD
Nandrolone phenpropionate—AR—lymph node—urinary bladder cancer	0.00845	0.0148	CbGeAlD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PHB—urinary bladder cancer	0.00831	0.021	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—ESR2—urinary bladder cancer	0.00773	0.0196	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—ESR2—urinary bladder cancer	0.00764	0.0193	CbGpPWpGaD
Nandrolone phenpropionate—Etonogestrel—ESR1—urinary bladder cancer	0.00737	0.219	CrCbGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00611	0.0155	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00598	0.0151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.0059	0.0149	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—NCOR1—urinary bladder cancer	0.0059	0.0149	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTO2—urinary bladder cancer	0.00567	0.0143	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—NAT1—urinary bladder cancer	0.00567	0.0143	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.0056	0.0142	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—ESR1—urinary bladder cancer	0.00522	0.155	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.00519	0.0131	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00512	0.0129	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—NCOR1—urinary bladder cancer	0.00504	0.0127	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—ESR1—urinary bladder cancer	0.00469	0.0119	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.00467	0.0118	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—ATM—urinary bladder cancer	0.00467	0.0118	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—CDK4—urinary bladder cancer	0.00465	0.0118	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00461	0.0117	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—PPARG—urinary bladder cancer	0.00428	0.0108	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—ESR1—urinary bladder cancer	0.00417	0.0105	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.00371	0.00937	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—CREBBP—urinary bladder cancer	0.00366	0.00925	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.00348	0.00881	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CREBBP—urinary bladder cancer	0.00347	0.00877	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—RB1—urinary bladder cancer	0.00346	0.00874	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00338	0.00855	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.00326	0.00824	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—SRC—urinary bladder cancer	0.0032	0.0081	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.00315	0.00797	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CCNE1—urinary bladder cancer	0.00311	0.00787	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—NAT2—urinary bladder cancer	0.00311	0.00786	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—SRC—urinary bladder cancer	0.00308	0.00779	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00307	0.00775	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—NCOR1—urinary bladder cancer	0.00302	0.00764	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—urinary bladder cancer	0.0029	0.00734	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.00286	0.00723	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00266	0.00672	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.00264	0.00667	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.00257	0.0065	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.00256	0.00647	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.0025	0.00632	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—EP300—urinary bladder cancer	0.00249	0.0063	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—HPGDS—urinary bladder cancer	0.00249	0.00629	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CDKN2A—urinary bladder cancer	0.00247	0.00624	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—ESR1—urinary bladder cancer	0.00246	0.0733	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.00246	0.00622	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTT1—urinary bladder cancer	0.00241	0.0061	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—EP300—urinary bladder cancer	0.00236	0.00597	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—HRAS—urinary bladder cancer	0.00226	0.0057	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—urinary bladder cancer	0.00225	0.00569	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.00224	0.00567	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.00215	0.00543	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.00213	0.00537	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.00209	0.00528	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CCND1—urinary bladder cancer	0.00208	0.00527	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CREBBP—urinary bladder cancer	0.00208	0.00526	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—RB1—urinary bladder cancer	0.00207	0.00524	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—urinary bladder cancer	0.00198	0.00502	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—RHOA—urinary bladder cancer	0.00188	0.00476	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—urinary bladder cancer	0.0018	0.00455	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00179	0.00454	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.00169	0.00427	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—urinary bladder cancer	0.00168	0.00424	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTP1—urinary bladder cancer	0.00167	0.00423	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.00166	0.0042	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00165	0.00417	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—urinary bladder cancer	0.00163	0.00412	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.00161	0.00406	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.00157	0.00397	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.00156	0.00395	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.00156	0.00393	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—urinary bladder cancer	0.00154	0.0039	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CCND1—urinary bladder cancer	0.00154	0.00389	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTM1—urinary bladder cancer	0.00154	0.00388	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.00153	0.00386	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00151	0.00383	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CDKN1A—urinary bladder cancer	0.00149	0.00377	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PTEN—urinary bladder cancer	0.00149	0.00376	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.00147	0.00372	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EP300—urinary bladder cancer	0.00142	0.00358	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—SRC—urinary bladder cancer	0.00138	0.00349	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.00136	0.00343	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.00135	0.00342	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.00135	0.00341	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—urinary bladder cancer	0.00134	0.0034	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.00134	0.0034	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.00134	0.00338	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.00133	0.00337	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.00133	0.00336	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.0013	0.00329	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.00129	0.00327	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.00129	0.00326	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EGFR—urinary bladder cancer	0.00121	0.00305	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.00117	0.00296	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.00116	0.00294	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.00113	0.00286	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.00112	0.00282	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.00106	0.00267	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.00105	0.00267	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTZ1—urinary bladder cancer	0.00102	0.00259	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.00101	0.00255	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000974	0.00246	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTO2—urinary bladder cancer	0.00097	0.00245	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NAT1—urinary bladder cancer	0.00097	0.00245	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000954	0.00241	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000946	0.00239	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000928	0.00235	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000925	0.00234	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000905	0.00229	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UGT2B7—urinary bladder cancer	0.000887	0.00224	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000868	0.0022	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000838	0.00212	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000836	0.00211	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000815	0.00206	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000809	0.00205	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000809	0.00204	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000807	0.00204	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP4B1—urinary bladder cancer	0.000799	0.00202	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000799	0.00202	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000791	0.002	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000769	0.00195	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC19A1—urinary bladder cancer	0.000755	0.00191	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000748	0.00189	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000748	0.00189	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PRSS3—urinary bladder cancer	0.000735	0.00186	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000734	0.00186	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000696	0.00176	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000681	0.00172	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.00067	0.0017	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000664	0.00168	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000656	0.00166	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000643	0.00163	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.00064	0.00162	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000625	0.00158	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000619	0.00157	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00059	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TYMP—urinary bladder cancer	0.000588	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000584	0.00148	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SMC1A—urinary bladder cancer	0.000583	0.00147	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000572	0.00145	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000565	0.00143	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000561	0.00142	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000551	0.00139	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NAT2—urinary bladder cancer	0.000532	0.00134	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ESR2—urinary bladder cancer	0.000508	0.00129	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—RRM2—urinary bladder cancer	0.000459	0.00116	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HPGDS—urinary bladder cancer	0.000425	0.00107	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ENO2—urinary bladder cancer	0.000425	0.00107	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000423	0.00107	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTT1—urinary bladder cancer	0.000412	0.00104	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000406	0.00103	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NCOR1—urinary bladder cancer	0.000392	0.000992	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ERCC2—urinary bladder cancer	0.000369	0.000933	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NQO1—urinary bladder cancer	0.000343	0.000866	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000333	0.000842	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000332	0.000841	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ESR1—urinary bladder cancer	0.000308	0.00078	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.00029	0.000733	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTP1—urinary bladder cancer	0.000286	0.000723	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARG—urinary bladder cancer	0.000281	0.000711	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000276	0.000699	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CREBBP—urinary bladder cancer	0.00027	0.000683	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TYMS—urinary bladder cancer	0.000266	0.000672	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NCOR1—urinary bladder cancer	0.000263	0.000664	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM1—urinary bladder cancer	0.000263	0.000664	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GPX1—urinary bladder cancer	0.000251	0.000636	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	0.000247	0.000624	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	0.000232	0.000587	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARG—urinary bladder cancer	0.000188	0.000476	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	0.000181	0.000457	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MYC—urinary bladder cancer	0.00016	0.000406	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	0.000148	0.000374	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTEN—urinary bladder cancer	0.000129	0.000326	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—EP300—urinary bladder cancer	0.000123	0.000311	CbGpPWpGaD
